Analyst Groups Analyst Article on PolarCool: ‘First Mover Advantage on a Global Market With Vast Potential’
Analyst Group published, on the 11th of September 2023, an analyst article on PolarCool titled: ”First mover advantage on a global market with vast potential”, which can be accessed on Analyst Groups website and on www.polarcool.se.
The following is an extract from the article:
“PolarCool AB (“PolarCool” or the “Company”) is a MedTech company that has developed a unique, high-quality cooling unit with a positive clinically proven cooling effect on concussion recovery. By having a first mover advantage in a relatively unexploited industry, the Company has the opportunity to capitalize on an extensive market potential with the help of the in-house developed product PolarCap® System. By utilizing the benefits of the product, whose purpose is to minimize acute injuries of concussion, a lack of clear competitors, and a low valuation in comparison to comparable companies, Analyst Group sees an attractive position for investors to take part in the global scale-up ahead of PolarCool.”
For more information
Erik Andersson – CEO PolarCool AB (publ)
+46 - 738 60 57 00
E-mail: [email protected]
About PolarCool AB (publ)
PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.
PolarCool Board members and Management subscribe for all their unit rights in the company's ongoing rights issue
-The future for PolarCool is exciting and we welcome everyone, also new shareholders without unit rights, to participate in the rights issue. The registration form, memorandum and teaser are available on Nordic Issuing's website www.nordic-issuing.se, Spotlight Stock Market's website https://www.spo...
Styrelsemedlemmar och ledning i PolarCool tecknar samtliga sina uniträtter i bolagets pågående företrädesemission
-Framtiden för PolarCool är väldigt spännande och vi välkomnar alla, även nya aktieägare utan uniträtter att delta i emissionen. Anmälningssedel, prospekt och teaser finns tillgängligt på Nordic Issuings hemsida www.nordic-issuing.se, Spotlight Stock Markets hemsida www.spotlightstockmarket.com samt...
Integrum attends international expert workshop on osseointegration and bionic limb reconstruction
Mölndal, Sweden, September 27, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is attending an international meeting and workshop event gathering experts in the field of osseointegration and bionic limb reconstruction, at the prestigious Rizzoli Or...
Capital increase in Monsenso A/S as a result of warrants exercising of employees
The new shares are ordinary shares without any special rights and are freely transferable negotiable instruments. The new shares entitle to dividends and other rights in the company from the time of registration of the capital increase. The new shares will be admitted to listing on Nasdaq First Nort...